Introduction {#Sec1}
============

*Gastrodia elata*, a saprophytic herb from orchid family, mainly distributed in East Asia, Southeast Asia and Oceania. The main constituents of *G. elata* are phenolics, polysaccharides, sterols and organic acids \[[@CR1]\]. As a famous traditional Chinese medicine (TCM), the tuber of *G. elata* is commonly used for the treatment of diverse mental diseases, involving insomnia \[[@CR2], [@CR3]\], depression \[[@CR4]--[@CR7]\], epilepsy, convulsion \[[@CR8], [@CR9]\], and Alzheimer's disease \[[@CR10], [@CR11]\]. Plenty of pharmacological investigation suggested that *G. elata* had anti-hypertension \[[@CR12]\], anti-tumor \[[@CR13]\], anti-virus \[[@CR14], [@CR15]\] and anti-inflammation \[[@CR16], [@CR17]\] effects. Most of pharmacological components are 4-hydroxybenzyl alcohol, 4-hydroxybenzaldehyde, vanillin, 1,3-bis(4-hydroxybenzyl) citrate, 1-(4-beta-[d]{.smallcaps}-glucopyranosyloxybenzyl) citrate and parishin B \[[@CR18]\]. However few reports about the psychoactive effects of polybenzyls were published \[[@CR19]--[@CR22]\]. In this study, the EtOAc extract of *G. elata* was found to activate MT~2~ receptor with an agonistic rate of 105.38% at the concentration of 102.22 *μ*g/mL. In order to characterize the active constituents, three new compounds (**1--3**, Fig. [1](#Fig1){ref-type="fig"}) were obtained by various column chromatography. Herein, we report their isolation, structural elucidation and agonistic activities on melatonin (MT~1~ and MT~2~) receptors.Fig. 1Structures of compounds **1**--**3**

Results and Discussion {#Sec2}
======================

Structure Elucidation {#Sec3}
---------------------

Compound **1** had a molecular formula of C~34~H~30~O~5~ with 20 degrees of unsaturation, which was deduced from HRESIMS at *m/*z 517.2040 \[M−H\]^−^ (calcd 517.2020). The UV absorptions at 281 and 254 nm, and the IR absorptions at 3426, 1631, 1613, 1511 and 1439 cm^−1^ suggested the presence of hydroxyl and phenyl groups. In the ^1^H-NMR spectrum, three sets of protons \[*δ*~H~ 7.01 (4H, d, *J* = 8.3 Hz, H-2, H-6, H-2′‴, H-6′‴), 6.67 (4H, overlap, H-3, H-5, H-3′‴, H-5′‴); 6.93 (2H, d, *J* = 8.4 Hz, H-2‴, H-6‴), 6.67 (2H, overlap, H-3‴, H-5‴)\], and combining with ^1^H-^1^H COSY correlations of H-2/H-3, H-6/H-5, H-2′‴/H-3′‴, H-6′‴/H-5′‴, and of H-2‴/H-3‴, H-6‴/H-5‴ indicated the existence of 1,4-substituted aromatic rings. One set of protons \[*δ*~H~ 6.85 (1H, brs, H-6″), 6.84 (1H, *J* = 8.4, 2.0 Hz, H-4″), 6.67 (1H, overlap, H-3″)\], and combining with ^1^H-^1^H COSY correlation of H-3″/H-4″ manifested the presence of a 1,2,4-substitued benzene ring. Besides, two *meta*-coupled protons \[*δ*~H~ 6.77 (1H, d, *J* = 2.0 Hz, H-4′) and 6.76 (1H, d, *J* = 2.0 Hz, H-6′)\], four methylenes \[*δ*~H~ 3.79 (4H, s, H-7, H-7‴), 3.75 (2H, s, H-7′), 3.68 (2H, s, H-7″)\] were well recognized (Table [1](#Tab1){ref-type="table"}). Compared with 4-\[\[2-hydroxy-5-(methoxymethyl) phenyl\] methyl\]-2,6-bis \[(4-hydroxyphenyl) methyl\] phenol \[[@CR19]\], compound **1** had an extra *para*- hydroxybenzyl \[*δ*~H~ 6.93 (2H, d, *J* = 8.4 Hz, H-2‴, H-6‴), 6.67 (2H, overlap, H-3‴, H-5‴), 3.68 (2H, s, H-7″); *δ*~C~ 156.4 (C-4‴, s), 134.5 (C-1‴, s), 130.8 (C-2‴, C-6‴, d), 116.1 (C-3‴, C-5‴, d), 41.3 (C-7″, t)\], but with the absence of a methoxymethyl group. Based on the HMBC correlations from H-7″ (*δ*~H~ 3.68, s) to C-2‴, C-6‴ (*δ*~C~ 132.1, d), C-4″ (128.5, d), C-6″ (*δ*~C~ 132.2, d), the linkages of C-7″ to C-5″ and C-1‴ were established (Fig. [2](#Fig2){ref-type="fig"}). Thus, compound **1** was elucidated and named as gastropolybenzylol G.Table 1^1^H-NMR (400 MHz) and ^13^C-NMR (100 MHz) data of compound **1** in CD~3~ODNo.*δ*~H~ (*J* in Hz)*δ* ~C~No.*δ*~H~ (*J* in Hz)*δ* ~C~1--133.6 (s)3″6.67 (1H, overlap)116.0 (d)27.01 (1H, d, 8.3)130.9 (d)4″6.84 (1H, 8.4, 2.0)128.5 (d)36.67 (1H, overlap)116.0 (d)5″--133.8 (s)4--156.3 (s)6″6.85 (1H, brs)132.2 (d)56.67 (1H, overlap)116.0 (d)7″3.68 (2H, s)41.3 (t)67.01 (1H, 8.3)130.9 (d)1‴--134.5 (s)73.79 (2H, s)36.0 (t)2‴6.93 (1H, d, 8.4)130.8 (d)1′--129.6 (s)3‴6.67 (1H, overlap)116.1 (d)2′--154.2 (s)4‴--156.4 (s)3′--129.5 (s)5‴6.67 (1H, overlap)116.1 (d)4′6.77 (1H, d, 2.0)132.0 (d)6‴6.93 (1H, d, 8.4)130.8 (d)5′--134.4 (s)7‴3.79 (2H, s)35.9 (t)6′6.76 (1H, d, 2.0)132.0(d)1′‴--133.9 (s)7′3.75 (2H, s)35.9 (t)2′‴7.01 (1H, d, 8.3)130.9 (s)1″--129.4 (s)3′‴6.67 (1H, overlap)116.0 (d)2″--154.1 (s)4′‴--154.2 (s)5′‴6.67 (1H, overlap)116.0 (d)6′‴7.01 (1H, d, 8.3)130.9 (d) Fig. 2The key ^1^H-^1^H COSY and the HMBC correlations of compounds **1** and **2**

Compound **2** was assigned a molecular formula of C~17~H~20~O~4~ with 8 degrees of unsaturation according to the HRESIMS at *m/z* 333.1344 \[M+HCOO\]^−^ (calcd for 333.1344). The UV (274, 247 and 226 nm) and the IR (3423, 1613 and 1513 cm^−1^) absorptions showed the presence of hydroxyl and phenyl groups. Compared with 4,4′-hydroxybenzyl ether \[[@CR23]\], compound **2** had an additional ethoxymethoxyl group \[*δ*~H~ 5.21 (2H, s, H-8′), 3.70 (2H, q, H-9′), 1.18 (3H, t, H-10′); *δ*~C~ 94.2 (C-8′, t), 65.2 (C-9′, t), 15.5 (C-10′, q)\] in accordance with the HMBC correlation from H-8′ to C-9′. The HMBC correlation from H-8′ (*δ*~H~ 5.21, 2H, s) to C-4′ (*δ*~C~ 158.5, s) indicated the ethoxymethoxyl group at C-4′. Therefore, compound **2** was identified and named as gastropolybenzylol H.

Compound **3** showed a molecular formula of C~16~H~16~O~4~ with 9 degrees of unsaturation according to the \[M+H\]^+^ ion at *m/z* 273.1122 (calcd for 273.1121). The UV absorptions at 275, 250 and 229 nm suggested the existence of phenolic structure and the IR absorptions at 3430, 1703, 1614 and 1518 cm^−1^ manifested the presence of hydroxyl, carbonyl and phenyl groups. Compared with 4,4′-hydroxybenzyl ether \[[@CR23]\], compound **3** had an extra acetyl group \[*δ*~C~ 172.9 (s, C-8′), 21.0 (q, C-9′)\]. Thus, compound **3** was determined as the acetylated derivative of 4,4′-hydroxybenzyl ether and named as gastropolybenzylol I.

The known compounds were identified as 4, 4′-dimethoxy-dibenzyl ether \[[@CR24]\] (**4**), 4,4′-diethoxybenzyl ether \[[@CR25]\] (**5**), 4-\[(4-(methoxymethyl) phenoxy\] methyl\] phenol \[[@CR23]\] (**6**) and 4-\[\[4-\[\[4-(ethoxymethyl) phenoxy\] methyl\] phenoxy\] methyl\] phenol \[[@CR26]\] (**7**).

MT~1~ and MT~2~ Receptors Agonistic Activities {#Sec4}
----------------------------------------------

Compounds **1** and **2** were evaluated for their agonistic activities on MT~1~ and MT~2~ receptors in *vitro*. Melatonin was used as the positive control. As showed in Fig. [3](#Fig3){ref-type="fig"}, compound **1** could activate MT~1~ and MT~2~ receptors with agonistic rates of 55.91±4.84 and 165.13±5.65% at the concentration of 0.5 mM. Due to **1** with better agonistic activities on MT~2~ receptor, further study provided an EC~50~ value of 76.24 *μ*M on MT~2~ receptor (Fig. [4](#Fig4){ref-type="fig"}).Fig. 3MT~1~ and MT~2~ receptors agonistic activities of compounds **1** and **2** (0.5 mM). Data are expressed as mean ± S.D., n=3. Melatonin was used as the positive control with EC~50~ values of 1.0 nM (MT~1~) and 25.0 nM (MT~2~) Fig. 4Dose-dependent effects gastropolybenzylol G (**1**) on MT~2~ receptor

Experimental Section {#Sec5}
====================

General Procedures {#Sec6}
------------------

NMR spectra were undertaken by Avance III-400/III-600 spectrometers (Bruker, Bremerhaven, Germany). UV spectra were recorded on a UV-2401 equipment (Shimadzu, Kyoto, Japan). IR spectra were obtained on Bio-Rad FTS-135 (Hercules, California, USA) spectrometers using KBr pellets. LCMS-IT-TOF (Shimadzu, Kyoto, Japan) was used for detecting MS spectra. Thin-layer chromatography (TLC) analyses were performed on silica gel GF254 plates (Jiangyou, Chemical Co. Ltd., Yantai, China). Compounds were purified by silica gel (200--300 mesh, Qingdao Makall group Co. Ltd., Qingdao, China), Sephadex LH-20 (Amersham Biosciences, Sweden) column chromatography and HPLC using Shimadzu LC-CBM-20 system (Shimadzu, Kyoto, Japan) with an Agilent XDB-C~18~ column (9.4 × 250 mm, Agilient, California, USA). 10% H~2~SO~4~ in EtOH was applied for detecting spots by heating after sprayed. Melatonin as positive control was obtained from Damas-beta Co. Ltd. (Shanghai, China).

Plant Material {#Sec7}
--------------

*Gastrodia elata* Bl. was bought from Zhaotong in Yunnan Province of China, in September 2014, and was identified by Prof. Li-Gong Lei, Kunming Institute of Botany, CAS. A voucher specimen (No. 20141107) was deposited at the Laboratory of Anti-virus and Natural Medicinal Chemistry, Kunming Institute of Botany, CAS.

Extraction and Isolation {#Sec8}
------------------------

Fresh rhizomes of *G. elata* (45.0 kg) were cut into slices and extracted with 90% aqueous ethanol (45 L ×3) at room temperature. The combined extract was concentrated under reduced pressure and partitioned between H~2~O and EtOAc. The EtOAc extract (88 g) was separated by silica gel column chromatography (CC) using gradient elution with EtOAc-CHCl~3~ (0:100, 5:95, 10:90, 20:80, 40:60, 100:0, *v/v*) as the mobile phase to yield five fractions (Fr. 1--Fr. 5). Fr. 2 (22 g) was separated by silica gel CC with EtOAc-petroleum ether (5:95, 10:90, 20:80, 40:60, 100:0) to yield five fractions (Fr. 2.1--Fr. 2.5). Then, Fr. 2.2 (3.4 g) was further separated by silica gel CC (Me~2~CO-petroleum ether, 3:97, 5:95, 10:90, 20:80, 50:50) to give five fractions (Fr. 2.2.1--Fr. 2.2.5). Compounds **2** (10 mg) and **5** (30 mg) were purified from Fr. 2.2.1 by HPLC on an Agilent XDB-C~18~ column with the elution of MeCN--H~2~O (85:15, t~*R*~ = 30 min) and MeCN-H~2~O (90:10, t~*R*~ = 27 min), respectively. Compound **4** (24 mg) was isolated from Fr. 2.3 by Sephadex LH-20 (MeOH-CHCl~3~, 50:50) and finally purified by HPLC with the mobile phase of MeCN-H~2~O (60:40, t~*R*~ = 23 min). Fr. 2.4 was purified from by Sephadex LH-20 (MeOH-CHCl~3~, 50:50) and HPLC on an Agilent XDB-C~18~ column with the elution of MeCN-H~2~O (60:40, t~*R*~ = 20 min) to yield compound **3** (3.5 mg). Fr. 3 was subjected to silica gel CC (Me~2~CO-petroleum ether, 5:95, 10:90, 20:80, 40:60, 100:0) to yield five fractions (Fr. 3.1--Fr. 3.5). Fr 3.1 was isolated by silica gel CC (Me~2~CO-CHCl~3~, 5:95, 10:90, 20:80, 40:60, 100:0), Sephadex LH-20 CC (MeOH-CHCl~3~, 50:50), from which compounds **6** (2 mg, MeCN-H~2~O, 60:40, t~*R*~ = 25 min) and **7** (37 mg, MeCN-H~2~O, 45:55, t~*R*~ = 20 min) were obtained by HPLC purification. Further purification on Fr. 3.5 yielded compound **1** (10 mg) by silica gel CC, Sephadex LH-20 CC (MeOH-CHCl~3~ 50:50) and semi-preparative HPLC (MeCN-H~2~O, 30:70, t~*R*~ = 40 min).

*Gastropolybenzylol G (****1****)*, pale yellow powder, UV (MeOH) *λ*~max~ (log *ε*): 281 (4.03), 254 (3.25) nm; IR (KBr) *ν*~max~: 3426, 1631, 1613, 1511, 1439, 1247, 1229 cm^−1^; HRESIMS *m*/*z* 517.2040 \[M−H\]^−^ (calcd 517.2020). ^1^H-NMR and ^13^C-NMR data showed in Table [1](#Tab1){ref-type="table"}.

*Gastropolybenzylol H (****2****)*, yellow colloidal solid, UV (MeOH) *λ*~max~ (log *ε*): 275 (3.38), 248 (2.61), 226 (4.30) nm; IR (KBr) *ν*~max~: 3423, 1613, 1513, 1223, 1072, 1003 cm^−1^; HRESIMS *m*/*z* 333.1344 \[M+COOH\]^−^ (calcd 333.1344). ^1^H-NMR and ^13^C-NMR data showed in Table [2](#Tab2){ref-type="table"}.Table 2^1^H-NMR and ^13^C-NMR data of compounds **2** and **3** in CD~3~ODNo.**23***δ*~H~ (500 MHz, *J* in Hz)*δ*~C~ (125 MHz)*δ*~H~ (600 MHz, *J* in Hz)*δ*~C~ (150 MHz)1--130.2 (s)--129.9 (s)27.15 (1H, d, 8.6)130.9 (d)7.17(1H, d, 8.7)131.2 (d)36.75 (1H, d, 8.6)116.1 (d)6.85(1H, d, 8.7)116.0 (d)4--158.3 (s)--160.5 (s)56.75 (1H, d, 8.6)116.1 (d)6.85(1H, d, 8.7)116.0 (d)67.15 (1H, d, 8.6)130.9 (d)7.17 (1H, d, 8.7)131.2 (d)74.40 (2H, s)72.8 (t)4.92 (2H, s)71.2 (t)1′--132.7 (s)--129.4 (s)2′7.24 (1H, d, 8.7)130.6 (d)7.15 (1H, d, 8.5)130.6 (d)3′7.00 (1H, d, 8.7)117.2 (d)6.68 (1H, d, 8.5)116.3 (d)4′--158.5 (s)--158.6 (s)5′7.00 (1H, d, 8.7)117.2 (d)6.68 (1H, d, 8.5)116.3 (d)6′7.24 (1H, d, 8.7)130.6 (d)7.15 (1H, d, 8.5)130.6 (d)7′4.42 (2H, s)72.4 (t)4.85 (2H, s)67.3 (t)8′5.21 (2H, s)94.2 (t)--172.9 (s)9′3.70 (2H, q)65.2 (t)1.94 (3H, s)21.0 (q)10′1.18 (3H, t)15.5 (q)

*Gastropolybenzylol I (****3****)*, white powder, UV (MeOH) *λ*~max~ (log *ε*): 275 (3.48), 250 (2.89), 229 (4.42) nm; IR (KBr) *ν*~max~: 3430, 1703, 1614, 1518, 1268, 1245, 1029, 830 cm^−1^; HRESIMS *m*/*z* 273.1117 \[M+H\]^+^ (calcd 273.1121). ^1^H-NMR and ^13^C-NMR data showed in Table [2](#Tab2){ref-type="table"}.

Bioassay of Agonistic Activities on MT~1~ and MT~2~ Receptors {#Sec9}
-------------------------------------------------------------

Agonistic activities of compounds **1** and **2** were evaluated on HEK293 cell lines stably expressing the human melatonin MT~1~ and MT~2~ receptors. Referring to the previous study \[[@CR27], [@CR28]\], cells were cultivated by adding Dulbecco's modified eagle medium, G418 (400 *μ*g/mL) and fetal bovine serum (10%) in 5% CO~2~ incubator at 37 °C. Then, cells were put in a Matrigel^®^ coated 96-well black plate at a density of 4 × 10^4^/well and proliferated in CO~2~ for 24 h. Wash Free Fluo-8 Calcium Assay Kit (HD Biosicences Co. Ltd., Hd03-0010) was used for detecting calcium flow assay. Flex Station 3 Benchtop Multi-Mode Micro Plate Reader was applied for recording and reading data at room temperature using specified settings (excitation wave length, 485 nm, emission wave length, 525 nm, emission cut-off, 515 nm). EC~50~ values were calculated by GraphPad Prism 5 software.
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